Geron Corp. (GERN)
1.42
-0.05
(-3.40%)
USD |
NASDAQ |
Mar 05, 15:15
Geron Cash from Investing (Quarterly) : 21.14M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -419.50M |
| Recursion Pharmaceuticals, Inc. | -1.244M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| BioMarin Pharmaceutical, Inc. | -42.45M |
| Plus Therapeutics, Inc. | 1.297M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.07M |
| Cash from Financing (Quarterly) | 0.378M |
| Free Cash Flow | -110.95M |
| Free Cash Flow Per Share (Quarterly) | -0.0331 |
| Free Cash Flow to Equity (Quarterly) | -22.39M |
| Free Cash Flow to Firm (Quarterly) | -14.77M |
| Free Cash Flow Yield | -11.72% |